Penetration of ceftazidime into cerebrospinal fluid of patients with bacterial meningitis
Author(s) -
J Modaï,
Daniel Vittecoq,
J.M. Decazes,
Michel Wolff,
A. Meulemans
Publication year - 1983
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.24.1.126
Subject(s) - ceftazidime , cerebrospinal fluid , meningitis , antibiotics , medicine , bacterial meningitis , penetration (warfare) , pharmacokinetics , antibacterial agent , chromatography , anesthesia , chemistry , microbiology and biotechnology , surgery , biology , bacteria , pseudomonas aeruginosa , mathematics , genetics , operations research
Four 2-g doses of ceftazidime were infused intravenously over 30 min at 8-h intervals, first between days 2 and 4 and again between days 11 and 20, in 11 patients with bacterial meningitis undergoing treatment with other antibiotics. Concentrations of ceftazidime in serum and cerebrospinal fluid samples obtained 120 or 180 min after dose 4 were measured by high-pressure liquid chromatography. Concentrations in cerebrospinal fluid ranged from 2 to 30 micrograms/ml, depending on the sampling time and the time elapsed since the onset of the disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom